Influence of a non-ionic poloxamer surfactant, Pluronic F68, on protein release from poly(methylidene malonate 2.1.2) microparticles in simulated gastric and intestinal media

被引:0
作者
Le Visage, C
Couvreur, P
Passirani, C
Breton, P
Bru, N
Fattal, E
机构
[1] Univ Paris Sud, Fac Pharm, Pharm Galen Lab, CNRS,UMR 8612, F-92296 Chatenay Malabry, France
[2] Virsol, F-75116 Paris, France
来源
STP PHARMA SCIENCES | 2001年 / 11卷 / 05期
关键词
methylidene malonate; microencapsulation; oral administration; protein release; Pluronic F68;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We recently described a new microparticulate system based on poly(methylidene malonote 2.1.2). This paper focuses on an in vitro evaluation of this system for oral administration. Degradation studies, achieved in simulated gastric and intestinal media, have shown that size distribution and polymer molecular weight were not modified over an 8-h incubation period, confirming that such microparticles are suitable for oral administration. Ovalbumin release in these same media was very fast, with 90% released after 2 h. This release was attributed to the degradation of surface-bound protein, the distribution of which at the microparticle surface was confirmed by confocal microscopy. The addition of Pluronic F68 to the internal phase promoted ovalbumin location inside the internal globules, leading to a diminished release it? the same media. Almost 40,70 of ovalbumin can be considered as protected against degradation when Pluronic is added to the formulation. Therefore, a clear correlation was established between the modification of protein location within microparticles by Pluronic F68 and protection against degradation in simulated digestive media.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 27 条
[1]   Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres [J].
Allaoui-Attarki, K ;
Fattal, E ;
Pecquet, S ;
Trollé, S ;
Chachaty, E ;
Couvreur, P ;
Andremont, A .
VACCINE, 1998, 16 (07) :685-691
[2]   Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[3]   Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method [J].
BlancoPrieto, MJ ;
Leo, E ;
Delie, F ;
Gulik, A ;
Couvreur, P ;
Fattal, E .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1127-1129
[4]   Molecular mechanisms of the adsorption of a model protein (human serum albumin) on poly(methylidene malonate 2.1.2) nanoparticles [J].
Bousquet, Y ;
Swart, PJ ;
Schmitt-Colin, N ;
Velge-Roussel, F ;
Kuipers, ME ;
Meijer, DKF ;
Bru, N ;
Hoebeke, J ;
Breton, P .
PHARMACEUTICAL RESEARCH, 1999, 16 (01) :141-147
[5]  
BRUMAGNIEZ N, 1999, Patent No. 9955309
[6]  
BRUMAGNIEZ N, 1988, Patent No. 0283364
[7]   Labelling peptides with fluorescent probes for incorporation into degradable polymers [J].
Brunner, A ;
Minamitake, Y ;
Gopferich, A .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :265-273
[8]   Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery [J].
Cleek, RL ;
Ting, KC ;
Eskin, SG ;
Mikos, AG .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (2-3) :259-268
[9]   The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method [J].
Coombes, AGA ;
Yeh, MK ;
Lavelle, EC ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (03) :311-320
[10]   Single dose, polymeric, microparticle based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen [J].
Coombes, AGA ;
Lavelle, EC ;
Jenkins, PG ;
Davis, SS .
VACCINE, 1996, 14 (15) :1429-1438